ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,367Medicare Part D Prescriptions Filled, Including Refills
$527K Total Retail Price of All Prescriptions
756 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
AMLODIPINE BESYLATE 647 577
CARVEDILOL 527 444
LISINOPRIL 476 402
PRAVASTATIN SODIUM 457 385
FUROSEMIDE 441 379
WARFARIN SODIUM 427 383
METOPROLOL SUCCINATE 374 345
PLAVIX 361 302
POTASSIUM CHLORIDE 359 311
HYDROCHLOROTHIAZIDE 330 269
ISOSORBIDE MONONITRATE ER 316 261
SIMVASTATIN 312 284
CLOPIDOGREL 311 242
METOPROLOL TARTRATE 303 277
DIOVAN 227 211
TRANDOLAPRIL 169 158 10
LOSARTAN POTASSIUM 161 147
LEVOTHYROXINE SODIUM 153 153
BISOPROLOL FUMARATE 147 146
CRESTOR 139 116
LOSARTAN-HYDROCHLOROTHIAZIDE 139 139
ATORVASTATIN CALCIUM 116 96
DILTIAZEM 24HR CD 112 100
DILTIAZEM 24HR ER 99 93
ENALAPRIL MALEATE 90 62
DILTIAZEM ER 82 82
OMEPRAZOLE 77 56
DIGOXIN 76 46
CLONIDINE HCL 74 52
ATENOLOL 74 68
SPIRONOLACTONE 73 64
BYSTOLIC 70 58
SOTALOL 67 62
ISOSORBIDE MONONITRATE 65 55
FAMOTIDINE 65 54
RAMIPRIL 65 65
CILOSTAZOL 63 61
BENICAR 63 63
DIOVAN HCT 62 57
NEXIUM 61 56
AMITRIPTYLINE HCL 60 40 R
VYTORIN 59 59
LIPITOR 55 46
PANTOPRAZOLE SODIUM 53 53
AMIODARONE HCL 50 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.